Skip to main content

. 1982 Jul;46(1):138–141. doi: 10.1038/bjc.1982.175

6-Mercaptopurine: apparent lack of relation between prescribed dose and biological effect in children with leukaemia.

S Herber, L Lennard, J S Lilleyman, J Maddocks

PMCID: PMC2011067 PMID: 6954968

138

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Fletcher L., Maddocks J. L. Assay of thioinosinic acid, an active metabolite of azathioprine, in human lymphocytes. Br J Clin Pharmacol. 1980 Sep;10(3):287–292. doi: 10.1111/j.1365-2125.1980.tb01757.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Kearney P. J., Light P. A., Preece A., Mott M. G. Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia. Cancer Chemother Pharmacol. 1979;3(2):117–120. doi: 10.1007/BF00254982. [DOI] [PubMed] [Google Scholar]
Lilleyman J. S., French A. J., Young I. P. Variation in 17 oxogenic steroid excretion following oral prednisolone in children with lymphoblastic leukaemia. Oncology. 1981;38(5):274–276. doi: 10.1159/000225569. [DOI] [PubMed] [Google Scholar]
Pinkerton C. R., Welshman S. G., Glasgow J. F., Bridges J. M. Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia? Lancet. 1980 Nov 1;2(8201):944–946. doi: 10.1016/s0140-6736(80)92105-4. [DOI] [PubMed] [Google Scholar]
Simone J. V. The treatment of acute lymphoblastic leukaemia. Br J Haematol. 1980 May;45(1):1–4. doi: 10.1111/j.1365-2141.1980.tb03804.x. [DOI] [PubMed] [Google Scholar]
Smith S. D., Rosen D., Trueworthy R. C., Lowman J. T. A reliable method for evaluating drug compliance in children with cancer. Cancer. 1979 Jan;43(1):169–173. doi: 10.1002/1097-0142(197901)43:1<169::aid-cncr2820430125>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES